Trials / Completed
CompletedNCT04387266
To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC
A Retrospective Real-world Study in Patients With Nasopharyngeal Carcinoma: to Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 471 (actual)
- Sponsor
- Fujian Cancer Hospital · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a retrospective real-world study to evaluate the efficacy and feasibility of modified reduce-volume target IMRT in the treatment of patients with non-metastatic NPC
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | modified reduce-volume target IMRT | The gross tumor volume of the nasopharynx and neck nodes (GTVnx and GTVnd) were delineated according to the tumor extension. The CTVnx was defined as GTVnx + nasopharynx mucosa + 8mm +corresponding anatomical structure without the delineation of CTV1. The CTVnd was defined as GTVnd plus the elective neck area. The prescribe doses of GTVnx/GTVnd, CTVnx, CTVnd were 66-70Gy,54-56Gy and 50-54Gy in 31-35 fractions, respectively. |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2020-08-01
- Completion
- 2020-10-01
- First posted
- 2020-05-13
- Last updated
- 2020-10-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04387266. Inclusion in this directory is not an endorsement.